You asked, we listened
We’re changing how we communicate
We asked our Patient Panel if there’s anything we can do to improve. One of the things you told us is that you’d like faster, more frequent communication from us. You also asked us to find a better way of contacting you. One that’s kinder to our planet.
Based on this feedback, we’d like to know if you would prefer to be contacted via email moving forward?
We hope you’ll agree email is a much more sustainable way for us to keep you up to date. By providing your email address, we can let you know about key service or product updates that might affect you. You’ll also receive this information much quicker than in the post.
If you don’t wish to provide an email address, we will continue to send you updates in the usual way.
To make the switch, we’ll need your current email address, which we’ll retain on a confidential database.
Please submit your email address and complete the fields below:
HPN and Immunotherapy Homecare team call: 0800 121 8300
Biosimilars Homecare team call: 0800 090 2461
